The 35th Oncology Nursing Society (ONS) Congress

Humoring Your Patients

Laughter has long been rumored to have healing properties, and now a team of researchers from Hawaii has put that rumor to the test in a randomized study presented at the 35th annual meeting of the Oncology Nursing Society. Fifty patients undergoing chemotherapy to treat cancer were assigned to watch a 45-minute DVD, with one group viewing humorous content and the other group viewing non-humorous content.           
Before the patients watched the DVD, investigators took baseline measures of their symptoms using the Edmonton Symptom Assessment Scale (ESAS), evaluated their stress level according to the Spielberger State-Trait Anxiety Index (STAI-S), and tested their saliva for levels of immunoglobulin-A (IgA) and cortisol. These same tests were performed immediately after participants finished viewing their respective DVDs.  As part of the study, the researchers also interviewed patients and caregivers about their perceptions of the entire study experience. They used student T tests to analyze any variation in measures between baseline and post-viewing of the DVD.
Compared with baseline ESAS scores, patients who watched the humorous DVD subsequently demonstrated significant decreases in cancer- and chemotherapy-related symptoms (P = .04). Anxiety levels as assessed by STAI-S score also declined significantly (P = .03). Salivary IgA levels in the group that watched the humorous DVD increased, suggesting improved immune response (P = .03), though the difference between the two groups was not statistically significant.            

Interviews of participants following the DVD viewing showed that patients who watched the humorous DVD felt better physically and psychologically. They attributed these boosts to feeling more positive and relaxed after watching the DVD, which they said distracted them from the stress of their illness and the unpleasant effects of treatment.

This was only a small study, and it may be premature to suggest adopting a Patch Adams routine in an effort to humor your patients. The findings do support the idea of humor serving as a complement to pharmacological therapy when seeking to manage cancer symptoms and adverse effects related to chemotherapy. Humor is an "inexpensive, efficient, and effective intervention," the researchers concluded.

Most Popular

Recommended Reading

For patients with chronic lymphocytic leukemia, the Bruton tyrosine kinase inhibitor ibrutinib is effective, and prognosis is poor after discontinuation, according to a study published online Feb. 26 in JAMA Oncology. The research identifies, for the first time, baseline factors associated with ibrutinib therapy discontinuation.
Patients with metastatic colorectal cancer that started on the left side may be more likely to survive than those whose disease originated on the right side, according to research published in the March issue of the Journal of the National Cancer Institute.
US recommendations against the prostate-specific antigen test for prostate cancer might have prompted a small but measurable increase in the number of higher-risk cases diagnosed recently, according to a new study. Findings from the study are to be presented Thursday at the American Society of Clinical Oncology's annual Genitourinary Cancers Symposium, held from Feb. 26 to 28 in Orlando, Fla.
For aspirin-sensitive patients undergoing everolimus-eluting stent implantation, 6-month dual antiplatelet therapy is noninferior to 24-month DAPT, according to a study published in the March 3 issue of the Journal of the American College of Cardiology.
$vacMongoViewPlus$ $vAR$